Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan;48(1):211-219.
doi: 10.1007/s40279-017-0765-4.

Doping in Two Elite Athletics Competitions Assessed by Randomized-Response Surveys


Doping in Two Elite Athletics Competitions Assessed by Randomized-Response Surveys

Rolf Ulrich et al. Sports Med. .


Background: Doping in sports compromises fair play and endangers health. To deter doping among elite athletes, the World Anti-Doping Agency (WADA) oversees testing of several hundred thousand athletic blood and urine samples annually, of which 1-2% test positive. Measures using the Athlete Biological Passport suggest a higher mean prevalence of about 14% positive tests. Biological testing, however, likely fails to detect many cutting-edge doping techniques, and thus the true prevalence of doping remains unknown.

Methods: We surveyed 2167 athletes at two sporting events: the 13th International Association of Athletics Federations Word Championships in Athletics (WCA) in Daegu, South Korea in August 2011 and the 12th Quadrennial Pan-Arab Games (PAG) in Doha, Qatar in December 2011. To estimate the prevalence of doping, we utilized a "randomized response technique," which guarantees anonymity for individuals when answering a sensitive question. We also administered a control question at PAG assessing past-year use of supplements.

Results: The estimated prevalence of past-year doping was 43.6% (95% confidence interval 39.4-47.9) at WCA and 57.1% (52.4-61.8) at PAG. The estimated prevalence of past-year supplement use at PAG was 70.1% (65.6-74.7%). Sensitivity analyses, assessing the robustness of these estimates under numerous hypothetical scenarios of intentional or unintentional noncompliance by respondents, suggested that we were unlikely to have overestimated the true prevalence of doping.

Conclusions: Doping appears remarkably widespread among elite athletes, and remains largely unchecked despite current biological testing. The survey technique presented here will allow future investigators to generate continued reference estimates of the prevalence of doping.

Comment in

Similar articles

See all similar articles

Cited by 14 articles

See all "Cited by" articles


    1. Eur J Appl Physiol. 2011 Sep;111(9):2307-14 - PubMed
    1. PLoS One. 2013 Nov 13;8(11):e78702 - PubMed
    1. Clin Chem. 2011 Jul;57(7):943-7 - PubMed
    1. PLoS One. 2016 Oct 26;11(10 ):e0165103 - PubMed
    1. J Am Stat Assoc. 1965 Mar;60(309):63-6 - PubMed

LinkOut - more resources